Type a ticker — we pressure-test it against live facts, filings, and sentiment.
Bristol-Myers Squibb Company — Healthcare · Drug Manufacturers—General carries a Plainview business-quality score of 7.9/10, built deterministically from SEC filings and Yahoo Finance: revenue, margins, cash, valuation, and a confluence buy zone. The live X-Ray loads below.
On the fundamentals, Bristol-Myers Squibb Company shows trailing revenue of $48.48B, a 72.0% gross margin, net debt of $33.61B, EPS of 4.24, valued at about 2.7x times sales. X-Ray measures business quality only — momentum and entry timing live in Decide and Opportunity Cost.
Compare: BMY vs UNH · BMY vs JNJ · BMY vs LLY | Also: UNH, JNJ, LLY, PFE, MRK, ABBV